Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
12/2003
12/04/2003WO2003099793A1 1,2-azole derivatives with hypoglycemic and hypolipidemic activity
12/04/2003WO2003099776A1 Calcium receptor modulating arylalkylamines
12/04/2003WO2003099221A2 Methods for using jnk inhibitors for treating or preventing disease-related wasting
12/04/2003WO2003099192A2 Bis-aromatic alkanols
12/04/2003WO2003034989A3 α-HYDROXYARYLBUTANAMINE INHIBITORS OF ASPARTYL PROTEASE
12/04/2003US20030225158 Compounds that modulate PPAR activity and methods for their preparation
12/04/2003US20030225043 Especially for inhibiting type IV collagenase
12/04/2003CA2487315A1 1,2-azole derivatives with hypoglycemic and hypolipidemic activity
12/04/2003CA2487073A1 Methods for using jnk inhibitors for treating or preventing disease-related wasting
12/04/2003CA2486853A1 Bis-aromatic alkanols
12/03/2003EP1367045A1 Intermediate products, methods for their preparation and use thereof
12/03/2003EP1366024A2 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
12/03/2003EP1366012A2 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders
11/2003
11/27/2003WO2003097616A1 Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors
11/27/2003WO2003097047A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
11/27/2003WO2003096984A2 Drug therapy for celiac sprue
11/27/2003WO2003096979A2 Drug therapy for celiac sprue
11/27/2003WO2003014064A8 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists
11/27/2003US20030220505 Process and novel intermediates for preparing isoxazolin-3-ylacyl benzenes
11/27/2003US20030220375 N-biphenyl(substituted methyl) aminocycloalkane-carboxamide derivatives
11/27/2003US20030220315 Such as 3',3"-dibromo-4',4"-dimethoxy-5',5"-bis-(methoxycarbonyl)-1,1 -diphenylethene; for treating viral diseases/retroviruses
11/27/2003US20030220228 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/27/2003CA2487247A1 Drug therapy for celiac sprue
11/27/2003CA2484233A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
11/26/2003EP1364946A1 Isoxazoline derivative and herbicide comprising the same as active ingredient
11/26/2003EP1364659A1 Remedies for urinary diseases comprising lpa receptor controlling agents
11/26/2003EP1363879A2 Sulfide and disulfide compounds and compositions for cholesterol management and related uses
11/26/2003EP1363873A2 Peptide deformylase inhibitors
11/26/2003EP1363638A2 Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
11/25/2003US6652905 Piezoelectric element and process for production thereof
11/20/2003WO2003087062A3 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation
11/20/2003WO2003053352A3 Therapeutic compounds for treating dyslipidemic conditions
11/20/2003WO2003017946A3 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof
11/20/2003WO2003006447A3 Interaction inhibitors of tcf-4 with beta-catenin
11/20/2003WO2001085664A8 Compounds and methods for regulating bacterial growth and pathogenesis
11/20/2003US20030216580 Herbicide active materials
11/20/2003US20030216386 Isoxazoles and oxadiazoles as anti-inflammatory inhibitors of IL-8
11/20/2003US20030216381 Can bind to Prostaglandin E2 receptors, especially, EP3 receptor and/or EP4 receptor and show antagonizing activity, and may be useful for prevention and/or treatment of disease, for example, pain, allergy, Alzheimer's disease, cancer
11/20/2003US20030216375 Sulfonamide substituted diphenyl thiourea compounds; use thereof in treating IL-8, GRO alpha, GRO beta, GRO gamma, NAP-2, and ENA-78 mediated diseases
11/20/2003US20030215438 Enzyme treatment of foodstuffs for celiac sprue
11/19/2003EP1362849A2 Process for production of piperidine derivatives
11/19/2003EP1362039A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
11/19/2003EP1362027A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/19/2003CN1456555A Isooxazole azo-group cycloethylene ketone metal chelates and their preparations
11/18/2003US6649639 Inhibit or block the biological activity of the picornaviral 3C protease.
11/18/2003US6649635 Heteroarylcarboxamide compounds active against protein tyrosine kinase related disorders
11/18/2003US6649629 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/13/2003WO2003093250A2 Positive allosteric modulators of the nicotinic acetylcholine receptor
11/13/2003WO2003092682A1 Zonisamide use in obesity and eating disorders
11/13/2003WO2002098849A3 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer’s disease and similar diseases
11/13/2003WO2002083622A3 Novel aminophenyl ketone derivatives
11/12/2003EP1115707B1 Benzamide derivatives and ther use as cytokine inhibitors
11/12/2003EP0996618B1 Endothelin antagonists: n- 2'- (4,5-dimethyl-3-isoxazolyl) amino]sulfonyl]-4-(2-oxazolyl) 1,1'-biphenyl]-2-yl]methyl] -n,3,3-trimethylbutanamide and n-(4,5-dimethyl-3-isoxazolyl) -2'- (3,3-dimethyl-2-oxo-1-pyrrolidinyl) methyl] -4'-(2-oxazolyl) 1,1'-biphenyl]-2-sulfonamide and salts thereof
11/12/2003CN1127491C Process crystallising N-(4-trifluoromethylphenyl)-5-methyl-isoxazole-4-carboxamide
11/11/2003US6646149 Derivitives of spermine or its N12-t-butyl carbamate
11/11/2003US6646137 Non-peptide GnRH agents
11/11/2003US6645919 3-(4,5-Dihydroisoxazol-5-yl)benzoylcyclohexenones and the use thereof as herbicides
11/06/2003WO2003090539A1 3-heteroaryl substituted 5-methyloxymethyl isoxazolines used as herbicides
11/06/2003US20030208084 Sulfonamides and derivatives thereof that modulate the activity of endothelin
11/06/2003US20030208068 Base-promoted isomerization of 3-unsubstituted-4-arylisoxa-zoles, followed by acidification of the enolates provides the title compound; coupling; efficiency; chemical intermediates for corticotropin releasing factor (CRF) receptors
11/06/2003US20030207934 Such as ((S)-1-benzyl-2-oxo-but-3-enyl)-carbamic acid tert-butyl ester; for treating human immunodeficiency virus; antimalarial agents
11/06/2003US20030207929 Microbiocides; bactericides
11/06/2003US20030207927 Phenyl benzisoxazoles as estrogenic agents
11/06/2003US20030207922 Diketoacids useful as inhibitors of viral polymerases, in particular hepatitis C virus, RNA dependent RNA polymerase, hepatitis B virus polymerase and reverse transcriptase of human immunodeficiency virus
11/06/2003US20030207894 1,4-Disubstituted benzenes as insecticides
11/06/2003CA2481793A1 3-heteroaryl substituted 5-methyloxymethyl isoxazolines used as herbicides
11/04/2003US6642418 Processes for preparing intermediates
11/04/2003US6642252 Anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer.
11/04/2003US6642251 Antitumor, 2-indolinone derivatives
10/2003
10/30/2003WO2003089404A1 Naphthalene amides as potassium channel openers
10/30/2003WO2003088959A2 Treatment of parkinson's disease with cyclooxygenase-2 (cox 2) inhibitor(s)
10/30/2003WO2002069901A3 Cathepsin cysteine protease inhibitors
10/30/2003WO2002064136A3 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/30/2003US20030203952 Novel processes for making- and a new crystalline form of- leflunomide
10/30/2003CA2482510A1 Monotherapy for the treatment of parkinson`s disease with cyclooxygenase-2 (cox 2) inhibitor(s)
10/29/2003EP1355921A2 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof
10/29/2003EP0779281B1 Isoxazoles
10/29/2003CN1452483A IL-8 receptor antagonists
10/28/2003US6639082 Cycloboronate intermediates; endothelin antagonists useful, inter alia, for the treatment of hypertension.
10/28/2003US6639078 Assays for ligands for nuclear receptors
10/28/2003US6638958 3-nitroisoxazoles and their use in the protection of materials
10/28/2003US6638957 Inhibition of 1-deoxy-D-xylulose-5-phosphate metabolic pathway
10/28/2003US6638937 As antihypertensive agents; for therapy of disorders related to renal, glomerular and mesangial cell function; therapy of endotoxemia or endotoxin shock as well as hemorrhagic shock; useful in alleviation of pain associated cancer
10/28/2003US6638931 Aminoguanidines and alkoxyguanidines as protease inhibitors
10/23/2003WO2003087084A1 3-aminophenol derivatives and dyes that contain these compounds while serving to dye keratin fibers
10/23/2003WO2003087062A2 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation
10/23/2003WO2003087037A1 Substituted aryl amides
10/23/2003WO2003086391A1 New use
10/23/2003WO2003086287A2 Compounds and methods for inducing apoptosis in proliferating cells
10/23/2003US20030199699 3-(4,5-Dihydroisoxaxol-5-yl)benzoylcyclohexenones and the use thereof as herbicides
10/23/2003US20030199578 Naphthalene amides as potassium channel openers
10/23/2003US20030199510 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
10/23/2003US20030199482 Anticholesterol agents; a drug mixture for treating hypercholesterolemia comprising an apical sodium co-dependent bile acid transport inhibitor, enzyme inhibitors of a cyclooxygenase-2
10/23/2003CA2485679A1 Compounds and methods for inducing apoptosis in proliferating cells
10/23/2003CA2481184A1 Medicament for preventing and/or treating chronic rejection
10/23/2003CA2480856A1 Substituted aryl amides
10/22/2003EP1353911A1 Antiviral agents
10/22/2003EP1353898A2 Compounds to treat alzheimer's disease
10/22/2003EP1353662A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
10/22/2003CN1450993A Fungicidal heterocyclic aromatic amides and their compositions methods of use and preparation
1 ... 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 ... 115